Case Report of a DDX41 Germline Mutation in a Family with Multiple Relatives Suffering from Leukemia

被引:0
作者
Wagner, Jan Nicolai [1 ]
Al-Bazaz, Maximilian [1 ]
Forstreuter, Anika [1 ]
Hammada, Mohammad Ibrahim [1 ]
Hille, Jurek [1 ]
Papingi, Dzhoy [2 ]
Bokemeyer, Carsten [1 ]
Fiedler, Walter [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplantat, Div Pneumol, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany
关键词
acute leukemia; DDX41; germline mutation; CPX-351; genetics; ACUTE MYELOID-LEUKEMIA; LANDSCAPE; VARIANTS; COHORT;
D O I
10.3390/biomedicines12010064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Previously, it was assumed that genetic influence played a minor role in acute myeloid leukemia (AML). Increasing evidence of germline mutations has emerged, such as DDX41 germline mutation associated with familial AML. Case presentation: A 64-year-old male patient presented with reduced exercise tolerance and shortness of breath. Following confirmation of AML diagnosis, the patient was enrolled into the AMLSG-30-18 study with a requirement for allogenic stem cell transplantation. The sister was initially selected as a fully HLA-matched donor. However, the family history showed risks for familial AML. Due to the striking family history, further diagnostic steps were initiated to detect a germline mutation. Methods: Using NGS in the patients' bone marrow AML sample, a DDX41 mutation with a VAF of 49% was detected, raising the possibility of a germline mutation. DNA from cheek swabs and eyebrows were tested for the presence of the DDX41 mutation in all siblings. Results: DDX41 germline mutation was detected in 5 out of 6 siblings. The sister was excluded as a related donor and the search for an unrelated donor was initiated. Conclusion: Obtaining family history of cancer patients plays a crucial role in oncology. If a germline mutation is suspected, further family work-up should be initiated.
引用
收藏
页数:10
相关论文
共 37 条
  • [11] Genetic predisposition to hematologic malignancies: management and surveillance
    Godley, Lucy A.
    Shimamura, Akiko
    [J]. BLOOD, 2017, 130 (04) : 424 - 432
  • [12] The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
    Khoury, Joseph D.
    Solary, Eric
    Abla, Oussama
    Akkari, Yassmine
    Alaggio, Rita
    Apperley, Jane F.
    Bejar, Rafael
    Berti, Emilio
    Busque, Lambert
    Chan, John K. C.
    Chen, Weina
    Chen, Xueyan
    Chng, Wee-Joo
    Choi, John K.
    Colmenero, Isabel
    Coupland, Sarah E.
    Cross, Nicholas C. P.
    De Jong, Daphne
    Elghetany, M. Tarek
    Takahashi, Emiko
    Emile, Jean-Francois
    Ferry, Judith
    Fogelstrand, Linda
    Fontenay, Michaela
    Germing, Ulrich
    Gujral, Sumeet
    Haferlach, Torsten
    Harrison, Claire
    Hodge, Jennelle C.
    Hu, Shimin
    Jansen, Joop H.
    Kanagal-Shamanna, Rashmi
    Kantarjian, Hagop M.
    Kratz, Christian P.
    Li, Xiao-Qiu
    Lim, Megan S.
    Loeb, Keith
    Loghavi, Sanam
    Marcogliese, Andrea
    Meshinchi, Soheil
    Michaels, Phillip
    Naresh, Kikkeri N.
    Natkunam, Yasodha
    Nejati, Reza
    Ott, German
    Padron, Eric
    Patel, Keyur P.
    Patkar, Nikhil
    Picarsic, Jennifer
    Platzbecker, Uwe
    [J]. LEUKEMIA, 2022, 36 (07) : 1703 - 1719
  • [13] DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosis
    Kobatake, Kohei
    Ikeda, Kenichiro
    Nakata, Yuichiro
    Yamasaki, Norimasa
    Kanai, Akinori
    Sekino, Yohei
    Takemoto, Kenshiro
    Fukushima, Takafumi
    Babasaki, Takashi
    Kitano, Hiroyuki
    Goto, Keisuke
    Hayashi, Tetsutaro
    Sentani, Kazuhiro
    Teishima, Jun
    Kaminuima, Osamu
    Hinata, Nobuyuki
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (10) : 456.e9 - 456.e18
  • [14] Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation
    Kobayashi, S.
    Kobayashi, A.
    Osawa, Y.
    Nagao, S.
    Takano, K.
    Okada, Y.
    Tachi, N.
    Teramoto, M.
    Kawamura, T.
    Horiuchi, T.
    Kato, S.
    Maekawa, T.
    Yamamura, T.
    Watanabe, J.
    Harada, Y.
    Harada, H.
    Sato, K.
    Kimura, F.
    [J]. LEUKEMIA, 2017, 31 (04) : 1020 - 1022
  • [15] Prevalence and significance of DDX41 gene variants in the general population
    Kovilakam, Sruthi Cheloor
    Gu, Muxin
    Dunn, William G.
    Marando, Ludovica
    Nik-Zainal, Serena
    Mohorianu, Irina
    Kar, Siddhartha P.
    Fabre, Margarete A.
    Quiros, Pedro M.
    Vassiliou, George S.
    [J]. BLOOD, 2023, 142 (14) : 1185 - 1192
  • [16] Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
    Lahtinen, Atte K.
    Koski, Jessica
    Ritari, Jarmo
    Hyvarinen, Kati
    Koskela, Satu
    Partanen, Jukka
    Vettenranta, Kim
    Koskenvuo, Minna
    Niittyvuopio, Riitta
    Salmenniemi, Urpu
    Itala-Remes, Maija
    Jahnukainen, Kirsi
    Kilpivaara, Outi
    Wartiovaara-Kautto, Ulla
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (01) : 39 - 45
  • [17] Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies
    Lewinsohn, Maya
    Brown, Anna L.
    Weinel, Luke M.
    Phung, Connie
    Rafidi, George
    Lee, Ming K.
    Schreiber, Andreas W.
    Feng, Jinghua
    Babic, Milena
    Chong, Chan-Eng
    Lee, Young
    Yong, Agnes
    Suthers, Graeme K.
    Poplawski, Nicola
    Altree, Meryl
    Phillips, Kerry
    Jaensch, Louise
    Fine, Miriam
    D'Andrea, Richard J.
    Lewis, Ian D.
    Medeiros, Bruno C.
    Pollyea, Daniel A.
    King, Mary-Claire
    Walsh, Tom
    Keel, Sioban
    Shimamura, Akiko
    Godley, Lucy A.
    Hahn, Christopher N.
    Churpek, Jane E.
    Scott, Hamish S.
    [J]. BLOOD, 2016, 127 (08) : 1017 - 1023
  • [18] The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms
    Li, Peng
    Brown, Sara
    Williams, Margaret
    White, Thomas
    Xie, Wei
    Cui, Wei
    Peker, Deniz
    Lei, Li
    Kunder, Christian A.
    Wang, Huan-You
    Murray, Sarah S.
    Vagher, Jennie
    Kovacsovics, Tibor
    Patel, Jay L.
    [J]. BLOOD, 2022, 140 (07) : 716 - 755
  • [19] AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome
    Li, Peng
    White, Thomas
    Xie, Wei
    Cui, Wei
    Peker, Deniz
    Zeng, Gang
    Wang, Huan-You
    Vagher, Jennie
    Brown, Sara
    Williams, Margaret
    Kovacsovics, Tibor
    Patel, Jay L.
    [J]. LEUKEMIA, 2022, 36 (03) : 664 - 674
  • [20] DDX41-associated susceptibility to myeloid neoplasms
    Makishima, Hideki
    V. Bowman, Teresa
    Godley, Lucy A.
    [J]. BLOOD, 2023, 141 (13) : 1544 - 1552